Discover Tenders by Non Distilled Fermented Beverages Sector

Find the most relevant tenders for Non Distilled Fermented Beverages. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Distilled Fermented Beverages tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Distilled Fermented Beverages tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Lipegfilgrastim L03Aa14 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5729395

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

239 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mebeverine A03Aa04 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5728537

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5727706

EMD:Ref Document

Bid Value: Ref Document

239 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ganirelix H01Cc01 Within The Framework Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5727688

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Pomalidomide Atc Code L04Ax06

Deadline: 27 Apr 2026

Germany

Ref. No.: 5727505

EMD:Ref Document

Bid Value: Ref Document

226 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Aclidinium Bromide Atc Code According To Who R03Bb05

Deadline: 28 Feb 2026

Germany

Ref. No.: 5727483

EMD:Ref Document

Bid Value: Ref Document

168 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tacrolimus L04Ad02 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5726196

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredients Bismuth Subcitrate Tetracycline And Metronidazole A02Bd08 As Part Of A So Called Open Hou

Deadline: 30 Apr 2026

Germany

Ref. No.: 5723430

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sirolimus L04Ah01 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5721216

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5720077

EMD:Ref Document

Bid Value: Ref Document

239 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5719969

EMD:Ref Document

Bid Value: Ref Document

240 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5719627

EMD:Ref Document

Bid Value: Ref Document

240 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5719561

EMD:Ref Document

Bid Value: Ref Document

239 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Estradiol G03Ca03 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5719391

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Showing 26056 to 26070 of 26345 results

‹
1
2
...
1735
1736
1737
1738
1739
1740
1741
...
1756
1757
›

Discover Tenders by Non Distilled Fermented Beverages Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Distilled Fermented Beverages Sector

Filter Your Search

FREE Trial plan for all new users!